Mode of delivery by an ulcerative colitis mother in a case of twins: Immunological differences in cord blood and placenta

Figure 2 Immunophenotyping of placental cells. A: Showing flow cytometry gating strategy for different immune cells in placenta. B: Representative dot plots showing T cells (CD3, CD4 and CD8), monocytes (CD14 and CD16) and NK cells (CD56 and CD16) in placenta of vaginally or C-section delivered newborns. C: Cumulative data showing percentages of different immune cells in placenta. D: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD4⁺ T cells. E: Percentages of PD-1, LAG-3 and TIM-3 on CD4⁺ T cells from placental tissues of twins. F: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD8⁺ T cells. G: Percentages of PD-1, LAG-3 and TIM-3 on CD8⁺ T cells from placental tissues of twins. H: Representative dot plots showing percentages of CD71⁺CD235⁺ cells in placental tissues of vaginally vs C-section delivered twins. I: Data showing levels of FCP in fecal samples of twins as measured by ELISA. NK: Natural killer; C-section: Caesarean section; PD-1: Program death-1; LAG-3: Lymphocyte-activation gene 3; TIM-3: T-cell immunoglobulin and mucin-domain containing-3; FCP: Fecal calprotectin; ELISA: Enzyme-linked immuno sorbent assay.